Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrullination | 4 | 2025 | 38 | 1.250 |
Why?
|
| Nucleotidyltransferases | 3 | 2026 | 66 | 1.120 |
Why?
|
| Alkynes | 1 | 2026 | 28 | 0.940 |
Why?
|
| Amides | 1 | 2026 | 61 | 0.920 |
Why?
|
| Membrane Proteins | 3 | 2026 | 926 | 0.900 |
Why?
|
| Benzimidazoles | 3 | 2023 | 55 | 0.820 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 13 | 0.790 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 347 | 0.750 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 645 | 0.560 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 517 | 0.540 |
Why?
|
| Protein-Arginine Deiminases | 4 | 2026 | 91 | 0.530 |
Why?
|
| Acetamides | 2 | 2026 | 17 | 0.470 |
Why?
|
| Structure-Activity Relationship | 4 | 2026 | 357 | 0.460 |
Why?
|
| Citrulline | 2 | 2025 | 46 | 0.420 |
Why?
|
| Enzyme Inhibitors | 2 | 2026 | 372 | 0.420 |
Why?
|
| Proteome | 2 | 2025 | 153 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 809 | 0.390 |
Why?
|
| Apoptosis | 2 | 2024 | 1099 | 0.250 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2023 | 65 | 0.240 |
Why?
|
| NF-kappa B | 2 | 2025 | 436 | 0.240 |
Why?
|
| Molecular Probes | 1 | 2026 | 34 | 0.240 |
Why?
|
| Neuroprotective Agents | 1 | 2026 | 80 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2025 | 859 | 0.230 |
Why?
|
| Hydrolases | 1 | 2026 | 84 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2025 | 269 | 0.230 |
Why?
|
| Triazoles | 1 | 2025 | 63 | 0.220 |
Why?
|
| Transcription Factor RelA | 1 | 2025 | 51 | 0.220 |
Why?
|
| Acute Lung Injury | 1 | 2025 | 45 | 0.220 |
Why?
|
| Mice | 7 | 2026 | 11184 | 0.210 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2026 | 97 | 0.210 |
Why?
|
| Siderophores | 1 | 2024 | 12 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2024 | 44 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 80 | 0.210 |
Why?
|
| Humans | 15 | 2026 | 65843 | 0.210 |
Why?
|
| Anthelmintics | 1 | 2024 | 47 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2024 | 95 | 0.200 |
Why?
|
| Premature Birth | 1 | 2025 | 116 | 0.200 |
Why?
|
| Animals | 10 | 2026 | 21492 | 0.200 |
Why?
|
| Cyclic GMP | 1 | 2023 | 33 | 0.200 |
Why?
|
| Herpes Simplex | 1 | 2023 | 49 | 0.200 |
Why?
|
| Proteomics | 1 | 2025 | 299 | 0.200 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 83 | 0.190 |
Why?
|
| NAD | 1 | 2023 | 54 | 0.190 |
Why?
|
| Axons | 1 | 2023 | 124 | 0.180 |
Why?
|
| Smad Proteins | 1 | 2022 | 23 | 0.180 |
Why?
|
| Osteogenesis | 1 | 2023 | 154 | 0.180 |
Why?
|
| Macrophages | 2 | 2025 | 1042 | 0.180 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 147 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 165 | 0.170 |
Why?
|
| Interferon Type I | 1 | 2023 | 198 | 0.170 |
Why?
|
| Proteins | 2 | 2023 | 764 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2025 | 3170 | 0.160 |
Why?
|
| Sepsis | 1 | 2024 | 309 | 0.160 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2020 | 4 | 0.160 |
Why?
|
| DNA Topoisomerases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 408 | 0.160 |
Why?
|
| Staphylococcus epidermidis | 1 | 2020 | 11 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 28 | 0.150 |
Why?
|
| A549 Cells | 1 | 2020 | 39 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2024 | 1044 | 0.150 |
Why?
|
| Indoles | 1 | 2020 | 112 | 0.150 |
Why?
|
| Quinazolines | 1 | 2019 | 21 | 0.150 |
Why?
|
| Quantum Dots | 1 | 2019 | 31 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 208 | 0.140 |
Why?
|
| Amino Acids | 1 | 2020 | 148 | 0.140 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 183 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2020 | 200 | 0.140 |
Why?
|
| Inflammation | 1 | 2025 | 1198 | 0.140 |
Why?
|
| HeLa Cells | 1 | 2020 | 541 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 198 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 186 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2020 | 718 | 0.110 |
Why?
|
| Pseudomonas Infections | 2 | 2025 | 73 | 0.100 |
Why?
|
| Molecular Structure | 2 | 2025 | 315 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2024 | 96 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 3506 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2025 | 132 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2023 | 14 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 712 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 2329 | 0.070 |
Why?
|
| Maze Learning | 1 | 2026 | 53 | 0.060 |
Why?
|
| Biotin | 1 | 2025 | 54 | 0.060 |
Why?
|
| RAW 264.7 Cells | 1 | 2025 | 50 | 0.060 |
Why?
|
| Lysine | 1 | 2025 | 93 | 0.060 |
Why?
|
| Trichuris | 1 | 2024 | 10 | 0.050 |
Why?
|
| Nematode Infections | 1 | 2024 | 10 | 0.050 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2024 | 12 | 0.050 |
Why?
|
| Placenta | 1 | 2025 | 73 | 0.050 |
Why?
|
| Arginine | 1 | 2025 | 136 | 0.050 |
Why?
|
| Ancylostoma | 1 | 2024 | 28 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2026 | 293 | 0.050 |
Why?
|
| Nematoda | 1 | 2024 | 33 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 57 | 0.050 |
Why?
|
| Extracellular Traps | 1 | 2024 | 45 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 116 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 102 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 93 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 625 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2023 | 200 | 0.050 |
Why?
|
| Wound Healing | 1 | 2023 | 193 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2022 | 50 | 0.050 |
Why?
|
| Virus Replication | 1 | 2023 | 323 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2024 | 617 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2023 | 273 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 178 | 0.040 |
Why?
|
| Cytokines | 1 | 2025 | 965 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 332 | 0.040 |
Why?
|
| Male | 3 | 2026 | 31410 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 1572 | 0.040 |
Why?
|
| Esterases | 1 | 2019 | 13 | 0.040 |
Why?
|
| Drug Liberation | 1 | 2019 | 23 | 0.040 |
Why?
|
| DNA | 1 | 2023 | 853 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 2401 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1391 | 0.030 |
Why?
|
| Lysosomes | 1 | 2019 | 176 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 719 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 588 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 709 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2031 | 0.030 |
Why?
|
| Female | 1 | 2025 | 34424 | 0.010 |
Why?
|